Outlook Therapeutics (OTLK) Shares Outstanding (Diluted) (2016 - 2026)
Outlook Therapeutics' Shares Outstanding (Diluted) came in at 136.74 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 270.0% from 36.96 million a year earlier and up 67.1% from the prior quarter.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Shares Outstanding (Diluted) (2016 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Outlook Therapeutics' Shares Outstanding (Diluted) was 34.8 million, up 87.6% from FY2024.
- Shares Outstanding (Diluted) has increased in each of the last five fiscal years, with a five-year compound annual growth rate of 57.2% (FY2020 to FY2025).
- Going back by fiscal year, Shares Outstanding (Diluted) was 18.55 million in FY2024 (+48.3%), 12.51 million in FY2023 (+18.0%), 10.6 million in FY2022 (+38.9%) and 7.63 million in FY2021 (+110.4%).
- The fiscal Q3 2026 figure represents the highest quarterly Shares Outstanding (Diluted) in data going back to fiscal Q2 2016.
- Year-over-year, Shares Outstanding (Diluted) has increased for 21 consecutive quarters, with growth averaging 120.9% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 11.2% in fiscal Q2 2024 to 270.0% in fiscal Q3 2026.
- Business Quant data shows OTLK's Shares Outstanding (Diluted) at 81.84 million (Q2 2026), 60.21 million (Q1 2026) and 34.8 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Outlook Therapeutics | 77.94 Mn | 42.19 Mn | -8,265.00 | 136.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 136.74 Mn |
| Mar 31, 2026 | 81.84 Mn |
| Dec 31, 2025 | 60.21 Mn |
| Sep 30, 2025 | 34.80 Mn |
| Jun 30, 2025 | 36.96 Mn |
| Mar 31, 2025 | 30.87 Mn |
| Dec 31, 2024 | 24.23 Mn |
| Sep 30, 2024 | 18.55 Mn |
| Jun 30, 2024 | 25.48 Mn |
| Mar 31, 2024 | 14.27 Mn |
| Dec 31, 2023 | 13.01 Mn |
| Sep 30, 2023 | 12.51 Mn |
| Jun 30, 2023 | 12.84 Mn |
| Mar 31, 2023 | 12.83 Mn |
| Dec 31, 2022 | 11.37 Mn |
| Sep 30, 2022 | 10.60 Mn |
| Jun 30, 2022 | 11.02 Mn |
| Mar 31, 2022 | 10.95 Mn |
| Dec 31, 2021 | 9.41 Mn |
| Sep 30, 2021 | 7.63 Mn |
API Access
Outlook Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();